Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mavis Mensah

Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Age-Related Alterations in Immune Contexture Are Associated With Aggressiveness in Rhabdomyosarcoma

English

Related publications

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology

English

MA04.07 MicroRNA-Based Liquid Biopsy Combines With PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients

Journal of Thoracic Oncology

English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy

Journal of Thoracic Oncology

English

PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer

Medicinski podmladak

2018

English

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

English

B7-H3 Expression in NSCLC and Its Association With B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Clinical Cancer Research

Cancer Research

Oncology

2017

English

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

British Journal of Cancer

Cancer Research

Oncology

2007

English

MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Mavis Mensah

Circulating microRNAs and PD-L1 Tumor Expression Are Associated With Survival in Advanced NSCLC Patients Treated With Immunotherapy: A Prospective Study

Age-Related Alterations in Immune Contexture Are Associated With Aggressiveness in Rhabdomyosarcoma

Related publications

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

MA04.07 MicroRNA-Based Liquid Biopsy Combines With PD-L1 Tumor Expression to Predict Response to Immunotherapy in Advance NSCLC Patients

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

MA10.05 Effect of Early Steroids Use in Advanced NSCLC Patients Treated With Immunotherapy

PD-1/PD-L1: A Novel Target for Immunotherapy in Patients With Advanced and Metastatic Non-Small Cell Lung Cancer

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

B7-H3 Expression in NSCLC and Its Association With B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Predictive Factors Associated With Prolonged Survival in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated With Gefitinib

MA19.02 Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples